Jonathan E. Lim, President, CEO at HALOZYME THERAPEUTICS INC (HALO), sold 5,900 shares at $10.67 ($62K) on 2007-05-31, disclosed to the SEC on 2007-06-01.
Scheduled sale ($62k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.51 | 200 | $2K | 3.4% |
| 2 | $10.52 | 900 | $9K | 15.2% |
| 3 | $10.53 | 200 | $2K | 3.4% |
| 4 | $10.54 | 200 | $2K | 3.4% |
| 5 | $10.55 | 300 | $3K | 5.1% |
| 6 | $10.56 | 463 |
| $5K |
| 7.8% |
| 7 | $10.57 | 1,137 | $12K | 19.2% |
| 8 | $10.58 | 200 | $2K | 3.4% |
| 9 | $10.61 | 400 | $4K | 6.8% |
| 10 | $10.62 | 400 | $4K | 6.8% |
| 11 | $10.63 | 100 | $1K | 1.7% |
| 12 | $10.64 | 300 | $3K | 5.1% |
| 13 | $10.66 | 300 | $3K | 5.1% |
| 14 | $10.67 | 200 | $2K | 3.4% |
| 15 | $10.68 | 100 | $1K | 1.7% |
| 16 | $10.69 | 200 | $2K | 3.4% |
| 17 | $10.70 | 200 | $2K | 3.4% |
| 18 | $10.72 | 100 | $1K | 1.7% |
| Total | $10.59 avg | 5,900 | $62K | 100% |
| Filing → |
| ERAS | BUY | 2023-06-08 | $275K | — | Filing → |
| ERAS | BUY | 2023-03-28 | $284K | — | Filing → |
| ERAS | BUY | 2023-01-10 | $232K | — | Filing → |